Your browser doesn't support javascript.
loading
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).
de Witte, Theo; Suciu, Stefan; Meert, Liv; Halkes, Constantijn; Selleslag, Dominik; Bron, Dominique; Amadori, Sergio; Willemze, Roel; Muus, Petra; Baron, Frédéric.
Afiliação
  • de Witte T; Radboud University Medical Centre, Nijmegen, The Netherlands. theo.dewitte@radboudumc.nl.
  • Suciu S; Department of Tumorimmunology, Radboud Institute of Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. theo.dewitte@radboudumc.nl.
  • Meert L; EORTC Headquarters, Brussels, Belgium.
  • Halkes C; EORTC Headquarters, Brussels, Belgium.
  • Selleslag D; Leiden University Medical Center, Leiden, The Netherlands.
  • Bron D; St Jan's Hospital, Brugge, Belgium.
  • Amadori S; Institut J. Bordet (ULB), Brussels, Belgium.
  • Willemze R; Tor Vergata University Hospital, Rome, Italy.
  • Muus P; Leiden University Medical Center, Leiden, The Netherlands.
  • Baron F; Radboud University Medical Centre, Nijmegen, The Netherlands.
Ann Hematol ; 94(12): 1981-9, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26410352

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article